4//SEC Filing
Lind Kevin Robert 4
Accession 0000950170-24-126650
CIK 0001832168other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 8:48 PM ET
Size
8.4 KB
Accession
0000950170-24-126650
Insider Transaction Report
Form 4
Lind Kevin Robert
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-11-13$3.12/sh+12,808$40,002→ 443,740 total - Gift
Common Stock
2024-11-13−80,000→ 363,740 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-13−12,808→ 255,377 totalExercise: $3.12Exp: 2030-10-26→ Common Stock (12,808 underlying)
Footnotes (3)
- [F1]Represents a cash exercise of vested stock options without a subsequent sale of the underlying shares of common stock.
- [F2]Represents shares of common stock gifted to a donor-advised trust.
- [F3]The shares subject to the stock option vested and became exercisable in 24 equal monthly installments commencing November 27, 2022.
Documents
Issuer
Longboard Pharmaceuticals, Inc.
CIK 0001832168
Entity typeother
Related Parties
1- filerCIK 0001677036
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 8:48 PM ET
- Size
- 8.4 KB